Crk-L Monoclonal Antibody

This gene encodes a protein kinase containing SH2 and SH3 (src homology) domains which has been shown to activate the RAS and JUN kinase signaling pathways and transform fibroblasts in a RAS-dependent fashion. It is a substrate of the BCR-ABL tyrosine kinase, plays a role in fibroblast transformation by BCR-ABL, and may be oncogenic.

Introducing the CRK-L Monoclonal Antibody, a cutting-edge biotechnological innovation designed to revolutionize the field of medical research and diagnostics. This meticulously crafted antibody is meticulously engineered to target and bind to the CRK-L protein, enabling precise detection and analysis of this crucial biomarker.

The CRK-L Monoclonal Antibody boasts exceptional specificity and sensitivity, ensuring accurate and reliable results in a wide range of applications. Its high affinity for the CRK-L protein guarantees optimal performance, facilitating the identification and quantification of this protein in various biological samples.

Crafted with utmost precision and utilizing state-of-the-art technology, this antibody exhibits exceptional stability and reproducibility, ensuring consistent and reproducible outcomes. Its robust design allows for seamless integration into various experimental protocols, making it an invaluable tool for researchers and clinicians alike.

Furthermore, the CRK-L Monoclonal Antibody is manufactured under stringent quality control measures, adhering to the highest industry standards. This guarantees the utmost purity and reliability of the product, minimizing the risk of false positives or erroneous results.

With its unparalleled performance and reliability, the CRK-L Monoclonal Antibody is poised to revolutionize the field of medical research and diagnostics. Whether employed in academic laboratories, pharmaceutical companies, or clinical settings, this antibody promises to enhance the accuracy and efficiency of CRK-L protein analysis, ultimately advancing our understanding of various diseases and facilitating the development of targeted therapies.

Choose the CRK-L Monoclonal Antibody and unlock a new era of precision and reliability in your research and diagnostic endeavors. Experience the power of cutting-edge biotechnology and elevate your scientific pursuits to unprecedented heights.